Observational analysis shows Ginsenoside Rg1 improves efficacy of hAD-MSCs in chemotherapy-induced ovarian insufficiency, suggesting a potential novel treatment approach.
Rg1 may promote the efficacy of hAD-MSC transplantation in alleviating chemotherapy-induced POI in rats. Rg1 might be a novel adjuvant drug to promote the efficacy of MSCs in the treatment of chemotherapy-induced POI.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: